Skip to content

Clinical trials

Phase 4 Memory Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Phase: Phase 4 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20052
20081
20101
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Texas Southwestern Medical Center2
Eisai Inc.1
Johns Hopkins University1
NYU Langone Health1
Neurognostics1
Novartis1
Rapoport, Alan, M.D.1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders9
Alzheimer Disease2
Cognitive Dysfunction1
Delirium1
Dementia1
Emergence Delirium1
Head Injuries, Closed1
Headache1
Multiple Sclerosis1
Multiple Sclerosis, Relapsing-Remitting1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.